Adult-onset Hallervorden-Spatz syndrome presenting as cortical dementia

Alzheimer Disease and Associated Disorders

Volumn 14, Issue 2, 2000, Pages 120-126

  Cooper, Greg E ^a   Rizzo, Matthew ^a   Jones, Robert D ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Dementia; Hallerworden Spatz syndrome; Neurodegeneration; Neuroimaging; Neuropsychology

Indexed keywords

ADULT; ARTICLE; BEHAVIOR; CASE REPORT; CLINICAL FEATURE; COGNITIVE DEFECT; DEMENTIA; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FEMALE; HALLERVORDEN SPATZ DISEASE; HISTOPATHOLOGY; HUMAN; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; AGE OF ONSET; CEREBRAL CORTEX; COGNITION DISORDERS; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HALLERVORDEN-SPATZ SYNDROME; HUMANS; MAGNETIC RESONANCE IMAGING; MOTOR SKILLS DISORDERS; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034096224     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-200004000-00010     Document Type: Article

References (24)

1. Alberca R, Rafel E, Chinchon I, Vadillo J, Navarro A. Late-onset Parkinsonian syndrome in Hallervorden-Spatz disease. J Neurol Neurosurg Psychiatry 1987;50:1665-8.
2. Benton Neuropsychology Laboratory. Manual of operations. Iowa City: University of Iowa, Department of Neurology, 1995.
3. Bornstein B, Sandbank U, Fried Y. Hallervorden-Spatz disease associated with Lewy type inclusions. Confin Neurol 1966;27:397-405.
4. Dooling EC, Schoene WC, Richardson EP. Hallervorden-Spatz syndrome. Arch Neurol 1974;30:70-83.
5. Eicke WJ. Neue Beobachtungen uber die Hallervorden-Spatzsche Krankheit. Arch Paychiatr Nervenkr 1940;111:514-46.
6. Feliciani M, Curatolo P. Early clinical and imaging (high-field MRI) diagnosis of Hallervorden-Spatz disease. Neuroradiology 1994;34: 247-8.
7. Garard T, Bots A, Staal A. Amyotrophic lateral sclerosis-dementia complex, neuroaxonal dystrophy, and Hallervorden-Spatz disease. Neurology 1973;23:35-9.
8. Gibb WRG. Idiopathic Parkinson's disease and the Lewy body disorders. Neuropathol Appl Neurobiol 1968;12:223-34.
9. Hallervorden J, Spatz H. Eigenartige Erkrankung im extrapyramidalen System mit besonderer Beteiligung des Globus pallidus und der Substantia nigra. Z Neurol Psychiatr 1922;79:254-302.
10. Lezak MD. Neuropsychological assessment. New York: Oxford University Press, 1995.
11. Jankovic J, Kirkpatrick JB, Blomquist KA, Langlais PJ, Bird ED. Late-onset Hallervorden-Spatz disease presenting as familial Parkinsonism. Neurology 1985;35:227-34.
12. Lowe J, Lennox G, Leigh P. Disorders of movement and system degenerations. In: Graham D, Lantos P, eds. Greenfield's neuropathology, II. London: Arnold, 1997:281-366.
13. Mattis S. Dementia Rating Scale. Odessa, FL: Psychological Assessment Resources, 1988.
14. Perry TL, Norman MG, Yong VW, et al. Hallervorden-Spatz disease: cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidus. Ann Neurol 1985;18:482-9.
15. Rizzuto N. Sur une degerescence pigmentaire pallido-reticulee (Hallervoden-Spatz) a evolution subaigue avec degerescence du systeme olfactif. Psychiatr Neurol 1967;154:177-200.
16. Rodnitzky RL. Hallervorden-Spatz syndrome. In: Stern MB, Koller WC, eds. Parkinsonian syndromes. New York: Marcel Dekker, 1993:341-58.
17. Rozdilsky B, Cumings JN, Huston AF. Hallervorden-Spatz disease -late infantile and adult types, report of two cases. Acta Neuropathol 1968;10:1-16.
18. Sacks O, Aguilar M, Brown W. Hallervorden Spatz disease: its pathogenesis and place among the axonal dystrophies. Acta Neuropathol 1966;6:164-74.
19. Schaffert DA, Johnsen SD, Johnson PC, Drayer BP. Magnetic resonance imaging in pathologically proven Hallervorden-Spatz disease. Neurology 1989;39:440-2.
20. Schochet S. Nutritional and metabolic disorders causing dementia. In: Markesbery W, ed. Neuropathology of dementing disorders. London: Arnold, 1998:377-92.
21. Sethi KD, Adams RJ, Loring DW, El Gammal T. Hallervorden-Spatz syndrome: clinical and magnetic resonance imaging correlations. Ann Neurol 1988;24:692-4.
22. Simma K. Verlauf der Hallervorden-Spatzschen Krankheit. Psychiatr Neurol 1957;133:39-45.
23. Swaiman KF. Hallervorden-Spatz syndrome and brain iron metabolism. Arch Neurol 1991;48:1285-93.
24. Taylor TD, Litt M, Kramer P, et al. Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20 p12.3-p13. Nat Genet 1996;14:479-81.